Document:AXA/2025/FY/Earnings release: Difference between revisions

Content deleted Content added
No edit summary
doc_archive: publish chq99br5nr (original transcript)
Line 10:
| pages = 20
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf
| archive_file = File:AXA<!-2025-FY ARCHIVE_MD_LINK_HERE -Earnings_release.md->
}}
 
 
 
Original PDF: [[Media:AXA-2025-FY-Earnings release.pdf|AXA-2025-FY-Earnings release.pdf]]
Line 20 ⟶ 18:
---
title: https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf
source_file: tmpl0ieedu_tmpn0gpcuni.pdf
source_url: https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf
doc_type: report
Line 27 ⟶ 25:
converter: anchor_injection/1
tier: economic
parsed_at: '2026-07-17T1417T15:5411:32Z48Z'
scanned_pages: []
---
Line 33 ⟶ 31:
 
{{pdf page|1|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf}}
Paris city, February 26th, 2026 (6:45am CET)
 
== Full Year 2025 Earnings ==
Line 288 ⟶ 286:
 
{{pdf page|6|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf}}
=== P&C underlying earnings were up 9% to Euro 5.9 billion driven by: ===
 
* Increase in technical result (Euro +0.5 billion) reflecting strong growth in volumes, combined with an improvement in technical margin; and
Line 295 ⟶ 293:
 
== Life & Health ==
 
 
<div style="overflow-x:auto">
{| id="t6" class="wikitable fintable"
|-
! colspan="4" style="text-align:leftcenter" | Key figures (in Euro billion, unless otherwise noted)
|-
|! style="text-align:left" |
! style="text-align:right" | FY24
! style="text-align:right" | FY25
Line 349 ⟶ 350:
{| id="t7" class="wikitable fintable"
|-
! colspan="4" style="text-align:leftcenter" | Earnings (in Euro million)
|-
! style="text-align:left" |
! style="text-align:right" | FY24
! style="text-align:right" | FY25
Line 371 ⟶ 374:
</div>
 
=== Gross written premiums & other revenues were up 8% to Euro 56.5 billion. ===
 
* '''Life''' grew by 9% to Euro 37.5 billion, mainly from:
* Unit-Linked (+13%) driven by successful sales initiatives across all geographies;
* G/A{{fn ref|13|2=General account.}} (+4%) notably in France (+4%) as well as from elevated sales of a capital-light product in Italy, partly offset by the non-repeat of elevated sales of a single premium whole-life product in Japan, and lower sales in Hong Kong; and
* Protection (11%), notably from a commercial campaign on a Protection with G/A product in Hong Kong and continued good sales of Protection with Unit-Linked product in Japan and Switzerland.
* '''Health''' grew by 5% to Euro 19.0 billion, driven by favorable price effects in both Group and Individual businesses across most geographies, partly offset by lower volumes.
 
{{pdf page|7|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf}}
Line 473 ⟶ 476:
{{pdf page|9|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf}}
== RATINGS AND GLOSSARY ==
 
 
* '''Operating variance''': the variation of the year-end CSM vs the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance.
 
 
* '''Present value of expected premiums (“PVEP”)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term. PVEP is discounted at the reference interest rate and PVEP is Group share.
 
 
* '''Technical experience''': consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows incurred in the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts and (iv) the other long-term elements which are mainly composed of non-attributable expenses.
 
 
* '''Underlying return on in-force''': the release of the time value of options & guarantees plus the unwind of CSM at the reference rate plus the underlying financial over-performance.
 
Line 490 ⟶ 486:
 
 
=== Scope ===
 
 
Line 508 ⟶ 504:
 
 
=== Exchange rates ===
 
 
Line 583 ⟶ 579:
{{fn note|1=23|2=AXA completed its acquisition of a majority stake in Prima in Italy on November 28, 2025.}}
{{fn note|1=24|2=Disposal to BNP Paribas completed on July 1, 2025.}}
 
All comments and changes are on a comparable basis for activity indicators (constant forex, scope and methodology).
 
Actuarial and financial assumptions used for the calculation of NBV and PVEP are updated on a semi-annual basis at half year and full year.
 
AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA’s statutory auditors.
 
{{pdf page|12|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf}}
The AXA Group is a worldwide leader in insurance, with 156,000 employees serving more than 92 million clients in 52 countries. In 2025, IFRS17 revenues amounted to Euro 115.5 billion and IFRS17 underlying earnings to Euro 8.4 billion.
The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 - Bloomberg: CS FP - Reuters: AXAF.PA). AXA's American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.
The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.
It is a founding member of the UN Environment Programme's Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.
This press release and the regulated information made public by AXA pursuant to article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1 et seq. of the Autorité des marchés financiers' General Regulation are available on the AXA Group website (axa.com).
THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE axa.com
 
 
== IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS AND THE USE OF NON-GAAP FINANCIAL MEASURES ==
Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans, expectations or objectives, and other information that is not historical information. Forward-looking statements are generally identified by words and expressions such as 'expects', 'anticipates', 'may', 'plan' or any variations or similar terminology of these words and expressions, or conditional verbs such as, without limitations, 'would' and 'could'. In particular, the statements in this press release regarding expected underlying earnings per share ('UEPS') growth for 2026 are forward-looking statements to provide one-off guidance in the context of the last year of the Group's current strategic plan. These statements and the others contained in the 'Outlook' section of this press release are based on Management's current views and intentions and are subject to change. Undue reliance should not be placed on forward-looking statements because, by their nature, they are subject to known and unknown risks and uncertainties, many of which are outside AXA's control, and can be affected by other factors that could cause AXA's actual results to differ materially from those expressed in, or implied or projected by, such forward-looking statements. Each forward-looking statement speaks only at the date of this press release. Please refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of certain important factors, risks and uncertainties that may affect AXA's business and/or results of operations. AXA specifically disclaims and undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as required by applicable laws and regulations.
In addition, this press release refers to certain non-GAAPnonGAAP financial measures, or alternative performance measures ('APMs'), used by Management in analyzing AXA's operating trends, financial performance and financial position and providing investors with additional information that Management believes to be useful and relevant regarding AXA's results. These non-GAAP financial measures generally have no standardized meaning and therefore may not be comparable to similarly labelled measures used by other companies. As a result, none of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS. 'Underlying earnings', UEPS ('underlying earnings per share'), 'underlying return on equity', 'combined ratio' and 'debt gearing' are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015. AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology, as applicable) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), on the pages indicated under the heading 'USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES'. For further information on the above-mentioned and other non-GAAPnonGAAP financial measures used in this press release, see the Glossary in AXA's 2025 Activity Report.
 
 
 
 
== FOR MORE INFORMATION: ==
 
The AXA Group is a worldwide leader in insurance, with 156,000 employees serving more than 92 million clients in 52 countries. In 2025, IFRS17 revenues amounted to Euro 115.5 billion and IFRS17 underlying earnings to Euro 8.4 billion.
 
=== Investor Relations: ===
 
&#32;Investor Relations: +33.1.40.75.48.42
+33.1.40.75.48.42
 
investor.relations@axa.com
 
Individual Shareholder Relations: +33.1.40.75.48.43
 
=== Individual Shareholder Relations: +33.1.40.75.48.43===
The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 - Bloomberg: CS FP - Reuters: AXAF.PA). AXA's American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.
 
+33.1.40.75.48.43
== Media Relations: ==
&#32;Media Relations: +33.1.40.75.46.74
ziad.gebran@axa.com ahlem.girard@axa.com sylwia.tulak@axa.com
 
=== Media Relations: ===
The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.
 
&#32;Media Relations: +33.1.40.75.46.74
== Corporate Responsibility strategy: ==
axa.com/en/about-us/strategy-commitments
 
ziad.gebran@axa.com
It is a founding member of the UN Environment Programme's Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.
ahlem.girard@axa.com
sylwia.tulak@axa.com
 
== SRI ratings: ==
axa.com/en/investor/sri-ratings-ethical-indexes
 
=== Corporate Responsibility strategy: ===
This press release and the regulated information made public by AXA pursuant to article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1 et seq. of the Autorité des marchés financiers' General Regulation are available on the AXA Group website (axa.com).
 
axa.com/en/about-us/strategy-commitments
THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE axa.com
 
== IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS AND THE USE OF NON-GAAP FINANCIAL MEASURES ==
 
=== SRI ratings: ===
Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans, expectations or objectives, and other information that is not historical information. Forward-looking statements are generally identified by words and expressions such as 'expects', 'anticipates', 'may', 'plan' or any variations or similar terminology of these words and expressions, or conditional verbs such as, without limitations, 'would' and 'could'. In particular, the statements in this press release regarding expected underlying earnings per share ('UEPS') growth for 2026 are forward-looking statements to provide one-off guidance in the context of the last year of the Group's current strategic plan. These statements and the others contained in the 'Outlook' section of this press release are based on Management's current views and intentions and are subject to change. Undue reliance should not be placed on forward-looking statements because, by their nature, they are subject to known and unknown risks and uncertainties, many of which are outside AXA's control, and can be affected by other factors that could cause AXA's actual results to differ materially from those expressed in, or implied or projected by, such forward-looking statements. Each forward-looking statement speaks only at the date of this press release. Please refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of certain important factors, risks and uncertainties that may affect AXA's business and/or results of operations. AXA specifically disclaims and undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as required by applicable laws and regulations.
 
axa.com/en/investor/sri-ratings-ethical-indexes
In addition, this press release refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management in analyzing AXA's operating trends, financial performance and financial position and providing investors with additional information that Management believes to be useful and relevant regarding AXA's results. These non-GAAP financial measures generally have no standardized meaning and therefore may not be comparable to similarly labelled measures used by other companies. As a result, none of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS. 'Underlying earnings', UEPS ('underlying earnings per share'), 'underlying return on equity', 'combined ratio' and 'debt gearing' are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015. AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology, as applicable) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), on the pages indicated under the heading 'USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES'. For further information on the above-mentioned and other non-GAAP financial measures used in this press release, see the Glossary in AXA's 2025 Activity Report.
 
{{pdf page|13|url=https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_Ib8FoBIGEg123_AXA_PR_20260226.pdf}}
Line 963 ⟶ 973:
<div style="overflow-x:auto">
{| id="t13" class="wikitable fintable"
|+ Interest Rates (5Y) For the Discounting of P&amp;C Claims Reserves
|-
! colspan="3" style="text-align:centerleft" | Interest Rates (5Y) For the Discounting of P&amp;C Claims Reserves
|-
| style="text-align:left" |
! style="text-align:right" | FY24{{fn ref|i|2=Calculated as monthly average from January 2024 to December 2024}}
! style="text-align:right" | FY25{{fn ref|ii|2=Average of monthly opening discount rates of 2025}}
Line 1,004 ⟶ 1,013:
 
 
=== P&C: Price effects i by country and business line ===
 
<div style="overflow-x:auto">
{| id="t14" class="wikitable fintable"
|+ P&amp;C: Price effects{{fn ref|i|2=i. Price effect calculated as a percentage of total gross written premiums in the prior year.}} by country and business line
|-
Line 1,016 ⟶ 1,025:
! style="text-align:left" | 2026 Market pricing trends
|-
!| style="text-align:left" | <strong>France</strong>
| style="text-align:right" | <strong>+4.0%</strong>
| style="text-align:right" | <strong>+3.3%</strong>
| style="text-align:right" |
| style="text-align:left" | Moderation of price increase
|-
!| style="text-align:left" | <strong>Europe</strong>
| style="text-align:right" | <strong>+3.1%</strong>
| style="text-align:right" | <strong>+5.4%</strong>
| style="text-align:right" |
| style="text-align:left" |
|-
!| style="text-align:left" | <iem>Switzerland</iem>
| style="text-align:right" | +3.0%
| style="text-align:right" | +5.0%
Line 1,034 ⟶ 1,043:
| style="text-align:left" | Continued price increases both in Personal and Commercial lines
|-
!| style="text-align:left" | <iem>Germany</iem>
| style="text-align:right" | +3.1%
| style="text-align:right" | +10.3%
Line 1,040 ⟶ 1,049:
| style="text-align:left" | Moderation of price increase, notably in Personal lines following two years of high price increases to counter claims inflation
|-
!| style="text-align:left" | <iem>Belgium &amp; Luxembourg</iem>
| style="text-align:right" | +2.5%
| style="text-align:right" | +4.4%
Line 1,046 ⟶ 1,055:
| style="text-align:left" | Price increase broadly in line with 2025
|-
!| style="text-align:left" | <iem>UK &amp; Ireland</iem>
| style="text-align:right" | +1.4%
| style="text-align:right" | -2.6%
Line 1,052 ⟶ 1,061:
| style="text-align:left" | In UK Personal lines, continuation of current trend, continued moderation in Commercial lines
|-
!| style="text-align:left" | <iem>Spain</iem>
| style="text-align:right" | +8.8%
| style="text-align:right" | +8.6%
Line 1,058 ⟶ 1,067:
| style="text-align:left" | Moderation of price increase
|-
!| style="text-align:left" | <iem>Italy</iem>
| style="text-align:right" | +5.2%
| style="text-align:right" | +5.3%
Line 1,064 ⟶ 1,073:
| style="text-align:left" | Moderation of price increase
|-
!| style="text-align:left" | <strong>AXA XL{{fn ref|ii|2=ii. Price increase on renewals at +0.3% in Insurance and +0.2% in Reinsurance. Price increase on renewals calculated as a percentage of renewed premiums.}}</strong>
| style="text-align:right" | <strong>+0.2%</strong>
| style="text-align:right" |
| style="text-align:right" | <strong>+0.3%</strong>
| style="text-align:left" | Softening prices with conditions varying by lines
|-
!| style="text-align:left" | <strong>Asia, Africa &amp; EME-LATAM</strong>
| style="text-align:right" | <strong>+3.8%</strong>
| style="text-align:right" | <strong>+7.1%</strong>
| style="text-align:right" |
| style="text-align:left" | Moderation of price increase
|-
!| style="text-align:left" | <strong>Total</strong>
| style="text-align:right" | <strong>+1.9%</strong>
| style="text-align:right" | <strong>+5.2%</strong>
| style="text-align:right" | <strong>+0.3%</strong>
| style="text-align:left" |
|}
Line 1,410 ⟶ 1,419:
Press release
 
=== Main transactions in 2025: ===
* Announced the execution of a share repurchase agreement in relation to AXA's share buyback program of up to Euro 1.2 billion (February 28, 2025)
* Announced the completion of the acquisition of Nobis Group in Italy (April 1, 2025)
Line 1,422 ⟶ 1,431:
* Announced the completion of the acquisition of a majority stake in Prima in Italy (November 28, 2025)
 
=== Next main investor events ===
* 2026 Shareholder's Annual General Meeting (April 30, 2026)
* First quarter 2026 Activity Indicators (May 5, 2026)